DMK

David M. Knott Portfolio holdings

AUM $264M
This Quarter Return
+22.93%
1 Year Return
+57.14%
3 Year Return
+78.48%
5 Year Return
+218.77%
10 Year Return
AUM
$221M
AUM Growth
+$221M
Cap. Flow
+$21.3M
Cap. Flow %
9.65%
Top 10 Hldgs %
55.64%
Holding
118
New
18
Increased
17
Reduced
14
Closed
8

Sector Composition

1 Healthcare 34.97%
2 Financials 19.59%
3 Materials 10%
4 Technology 8.95%
5 Industrials 8.38%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
LGND icon
1
Ligand Pharmaceuticals
LGND
$3.15B
$24.7M 11.16% 248,041
UPLD icon
2
Upland Software
UPLD
$81.4M
$18.7M 8.44% 406,500
FTAI icon
3
FTAI Aviation
FTAI
$15.8B
$16.4M 7.43% 700,000
APO icon
4
Apollo Global Management
APO
$77.9B
$14.7M 6.65% 300,000
DNMR
5
DELISTED
Danimer Scientific, Inc.
DNMR
$11.8M 5.32% +500,000 New +$11.8M
GOOG icon
6
Alphabet (Google) Class C
GOOG
$2.58T
$9.81M 4.44% 5,600
CLMT icon
7
Calumet Specialty Products
CLMT
$1.41B
$8.28M 3.75% 2,645,000 +625,000 +31% +$1.96M
MDWT
8
DELISTED
Midwest Holding Inc. Common Stock
MDWT
$7.71M 3.49% 143,621 +60,277 +72% +$3.23M
FSK icon
9
FS KKR Capital
FSK
$5.11B
$6.54M 2.96% 395,175
PFE icon
10
Pfizer
PFE
$141B
$4.41M 2% 119,900 -12,000 -9% -$442K
LKQ icon
11
LKQ Corp
LKQ
$8.39B
$4.23M 1.91% 120,000 -30,000 -20% -$1.06M
KKR icon
12
KKR & Co
KKR
$124B
$4.05M 1.83% 100,000
GILD icon
13
Gilead Sciences
GILD
$140B
$3.78M 1.71% 64,842 +53,842 +489% +$3.14M
KW icon
14
Kennedy-Wilson Holdings
KW
$1.21B
$3.76M 1.7% 210,000
EIGR
15
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$3.63M 1.64% 295,035 +19,687 +7% +$242K
ABBV icon
16
AbbVie
ABBV
$372B
$3.51M 1.59% 32,769 -5,000 -13% -$536K
VXX icon
17
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$262M
$3.36M 1.52% +200,000 New +$3.36M
EBC icon
18
Eastern Bankshares
EBC
$3.4B
$3.26M 1.48% +200,000 New +$3.26M
BMY icon
19
Bristol-Myers Squibb
BMY
$96B
$3.25M 1.47% 52,409 +6,000 +13% +$372K
HZNP
20
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$3.12M 1.41% 42,614 +5,083 +14% +$372K
XENE icon
21
Xenon Pharmaceuticals
XENE
$2.98B
$3.08M 1.39% 200,000 +23,000 +13% +$354K
KDMN
22
DELISTED
Kadmon Holdings, Inc.
KDMN
$2.91M 1.32% 702,000 +90,000 +15% +$373K
TGTX icon
23
TG Therapeutics
TGTX
$4.65B
$2.64M 1.2% 50,773
CAP.U
24
DELISTED
Capitol Investment Corp. V Units, each consisting of one share of Class A common stock, and one-thir
CAP.U
$2.58M 1.17% +250,000 New +$2.58M
TRIL
25
DELISTED
Trillium Therapeutics Inc.
TRIL
$2.57M 1.16% 174,699 -1,516 -0.9% -$22.3K